Johnson & Johnson
Search results
Explore Janssen’s innovative medical research & pharmaceutical product development practices to see how Janssen is creating a future where disease is a thing of the past.
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
Explore the Janssen United States site, and see how we collaborate with partners around the world to make patients healthier.
Jul 3, 2024 · Janssen has the following prescription pharmaceutical products in the United States. This information is intended for use by our customers, patients and healthcare professionals in the United States only.
NEW BRUNSWICK, N.J., February 27, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 ...
The Janssen Pharmaceutical Companies of Johnson & Johnson | 1,027,495 followers on LinkedIn. At Janssen, we never stop working toward a future where disease is a thing of the past.
Feb 27, 2021 · Discover 8 facts and things to know about Johnson & Johnson's Janssen COVID-19 vaccine, including how it works and how it might be manufactured and distributed.
Sep 1, 2021 · TITUSVILLE, N.J., Sept. 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved long-acting atypical antipsychotic INVEGA HAFYERA™ (6-month paliperidone palmitate), the first-and-only twice-yearly injectable for the treatment of schizophrenia in ...
We’re the Pharmaceutical Companies of Johnson & Johnson, and you can count on us to keep working tirelessly to make that future a reality for patients everywhere, by fighting sickness with...
In 1961, Johnson & Johnson acquired Janssen Pharmaceutica, the innovative drug company and research lab focused on public health. The company was founded in 1953 by Belgian-born Dr. Paul Janssen, one of the century’s most creative and prolific drug developers.
